Andere talen iCon Group Ltd

Aandelen

ICON

IL0011824849

Beurs gesloten - TEL AVIV STOCK EXCHANGE Andere beurzen 16:24:55 03-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
383,1 ^ILa	+0,03%		-3,14%	-18,14%

27/05	ICon Group Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
28/03	ICon Group Ltd rapporteert resultaten voor het gehele jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

ICon Group Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	27/05
ICon Group Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Radformation and Icon Group Unite to Transform Cancer Treatment and Workflows	14/02
Icon Group - Meet Our National Operations Manager for the UK, Claire Smith	12/02
Bowel Cancer Australia and Icon Cancer Centre announce new partnership to help close the care gap	08/02
Icon Singapore holds inaugural Regional Oncology Conference	30/01
Icon Singapore holds inaugural Radiation Oncology Conference	29/01
Icon - New radiation therapy service to give patients better access, more choice to cancer care	26/01
Icon Group and Nuffield Health announce next phase in strategic partnership for the delivery of oncology services in the UK	12/01
Icon Group celebrates a year of growth and pioneering advancements in healthcare	18/12
ICON secures upgraded credit rating from Moody's Investors Service	08/12
ICon Group Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
Icon Group Appoints Russell Hill as Chief Operating Officer for Pharmacy	29/11
Russell Hill appointed to Icon's Chief Operating Officer for Pharmacy	29/11
Icon takes centre stage at London Global Cancer Week	22/11
Icon Group - Slade Pharmacy wins contract to provide pharmacy services for UnitingCare Queensland hospitals	19-10-23
Icon Sunsuria set to open its first cancer centre in Island Hospital	18-10-23
Icon launches theranostics, a personalised approach to cancer treatment	10-10-23
Icon Group leads global initiative to support cancer care in war-torn Ukraine	28-09-23
ICon Group Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen iCon Group Ltd

Aandelen

ICON

IL0011824849

Andere talen

Filters